The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)
Description
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)
Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in microbiology, total microbiology market), by pathogen/disease (healthcare-acquired infections / antimicrobial resistance, STDs / women's health, hepatitis, HIV, respiratory tract infections, others), and by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world).
The report also looks at the global microbiology/infectious disease immunoassay 2017-2022 market by segment (laboratory-based immunoassays, rapid/point-of-care immunoassays, total microbiology/infectious disease immunoassay market), by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world), and by pathogen/disease indication (hepatitis, HIV, STDs, TORCH, respiratory, sepsis, parasitology, mycology, others).
There is a need for rapid tests that can quickly identify a microbial pathogen, and (if the pathogen is a bacteria) identify what antibiotic will be effective in treating the infection – all before a physician makes the treatment decision. This ideal test does not yet exist, but considerable advances are occurring in fields such as molecular microbiology and mass spectrometry in the microbiology laboratory. In addition, new technologies and platforms are being developed by companies that are working towards development of this much needed test. Beckman Coulter, Becton Dickinson, bioMérieux, and Thermo Fisher Scientific are among the market companies profiled in the report.91
Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in microbiology, total microbiology market), by pathogen/disease (healthcare-acquired infections / antimicrobial resistance, STDs / women's health, hepatitis, HIV, respiratory tract infections, others), and by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world).
The report also looks at the global microbiology/infectious disease immunoassay 2017-2022 market by segment (laboratory-based immunoassays, rapid/point-of-care immunoassays, total microbiology/infectious disease immunoassay market), by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world), and by pathogen/disease indication (hepatitis, HIV, STDs, TORCH, respiratory, sepsis, parasitology, mycology, others).
There is a need for rapid tests that can quickly identify a microbial pathogen, and (if the pathogen is a bacteria) identify what antibiotic will be effective in treating the infection – all before a physician makes the treatment decision. This ideal test does not yet exist, but considerable advances are occurring in fields such as molecular microbiology and mass spectrometry in the microbiology laboratory. In addition, new technologies and platforms are being developed by companies that are working towards development of this much needed test. Beckman Coulter, Becton Dickinson, bioMérieux, and Thermo Fisher Scientific are among the market companies profiled in the report.91
Table of Contents
272 Pages
- Overview
- Scope and Methodology
- Market Overview
- The Microbiology Laboratory
- Traditional Microbiology – Microbial Identification and Antibiotic Susceptibility Testing (ID/AST)
- Advances in Microbiology
- The Quest for Rapid Microbial Identification/Antibiotic Susceptibility (Resistance) Tests
- Burden of Infectious Disease
- Emerging Threats
- The Problem of Microbial Antibiotic Resistance
- Limitations of Traditional Microbiology
- Needed: Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
- Traditional Microbiology
- Mass Spectrometry
- Immunoassays
- Polymerase Chain Reaction and Other Nucleic Acid Amplification Technologies
- Liquid Microbiology and ID/AST Automation
- Advances in Microbial Identification Following Blood Culture
- Mass Spectrometry
- PCR and Other NAAT Based Tests for Infectious Diseases
- Next Generation Sequencing
- Applications of Molecular Testing in the Microbiology Laboratory – Selected Examples
- Multiplex Tests and Syndromic Testing
- DNA and RNA Sequencing in Microbiology
- "Rapid" Testing in Microbiology Labs Today – Faster Than Traditional Microbiology, But…
- Making Progress – Development of Faster Identification and Antimicrobial Susceptibility/Resistance Tests for the Microbiology Lab and Near Patient or Point-of-Care
- Investments and Financing Agreements
- Merger and Acquisitions
- Corporate Agreements and Collaborations
- Microbiology Company Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
- Cost of Molecular Microbiology Tests versus Traditional Microbiology
- Clinical Market Drivers
- Near-Patient and Point-of-Care Testing Market Drivers and Challenges/Hurdles
- Competition
- Regulation
- Reimbursement
- Future Prospects
- Worldwide Microbiology Market
- Traditional Microbiology ID/AST Market
- Microbiology/Infectious Disease Immunoassay Market
- Molecular Microbiology Market
- Microbiology Mass Spectrometry Market
- Future Market Potential for Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
- 3i Diagnostics, Inc. (3iDx)
- Abbott
- Accelerate Diagnostics, Inc.
- Atlas Genetics Ltd.
- AutoGenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
- bioMérieux SA
- Bruker Corporation
- Cepheid (A Danaher Company)
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- DiaSorin S.p.A.
- ELITech Group
- GenePOC Inc.
- GenMark Diagnostics, Inc.
- Hologic, Inc.
- Janssen Diagnostics (Janssen Pharmaceutical Companies of Johnson & Johnson)
- Luminex Corporation
- Mast Group
- Q-linea AB
- QIAGEN N.V.
- QuanDx Inc.
- QuantuMDx Group
- Quidel, Inc.
- Qvella Corporation
- Rheonix, Inc.
- Roche
- Siemens Healthineers
- THERMO FISHER SCIENTIFIC INC
- Xagenic Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.